Immunologic disorders and their role in the pathogenesis of toxic goiter
Epishin, A.V.
Klinicheskaia Meditsina 60(9): 77-81
1982
ISSN/ISBN: 0023-2149 PMID: 6983626 Document Number: 186756
Document emailed within 1 workday
Related Documents
Gaĭdina, G.A.; Gol'ber, L.M.; Kalenova, N.P.; Lazareva, S.P.; Prikhozhan, V.M. 1977: Reflex excitability of the spinal centers in patients with diffuse toxic goiter (concerning the pathogenesis of motor disorders) Problemy Endokrinologii 23(5): 24-29Derwahl, M. 1999: Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 93(Suppl 1): 25-28
Epishin, A.V. 1984: Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment Klinicheskaia Meditsina 62(8): 90-93
Karakhanian, E. 1978: Role of tuberculosis in etiology and pathogenesis of juvenile goiter Pediatriia 9: 48-50
Cheren'ko, M.P. 1972: Development of primary diffuse toxic goiter in a patient previously subjected to surgery for euthyroid nodular goiter Klinicheskaia Khirurgiia 9: 72-73
Vaia, E.; Bozzini, V.; Nicolò, M. 1988: The role of toxic cement in the pathogenesis of periodontitis Minerva Stomatologica 37(2): 147-150
Ukhal', M.I.; Drannik, G.N. 1990: The role of immunologic factors in the pathogenesis of urolithiasis Vrachebnoe Delo 1: 32-34
Buczyłko, K. 1978: Role of various immunologic phenomena in the pathogenesis of nasal polyps Otolaryngologia Polska 32(1): 119-120
Kieseier, B.C.; Storch, M.K.; Hartung, H.P. 2000: Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous system Journal of Neural Transmission. Supplementum 59: 69-80
Gandzha, I.M.; Miagkaia, I.P.; Furkalo, N.K. 1973: Role of the connective tissue and immunologic reactivity in the pathogenesis of arteriosclerosis Vrachebnoe Delo 3: 36-40
Baenkler, H.W. 1977: Immunologic disorders. 9. Immunologic defects and immunologic insufficiency, malignant immunoproliferation Fortschritte der Medizin 95(2): 71-75
Dabrowski, M.P.; Stankiewicz, W.; Chciałowski, A. 2003: The role of immunoregulatory disorders in pathogenesis of bronchial asthma Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(84): 522-523
Dedov, I.I.; Mel'nichenko, G.A.; Aleksandrova, G.F. 1992: Diffuse toxic goiter Klinicheskaia Meditsina 70(5-6): 65-70
Lazăr, C.; Diaconescu, M.R.; Strat, V.; Chifan, M.; Dolinescu, C.; Niculescu, D.; Luca, A.; Baran, T.; Rusu, M.; Pencea, V.; Gneazdovski, V. 1979: Toxic multiheteronodular goiter Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 83(4): 607-610
Golebiowska-Podgórczyk, I. 1975: Clinical and experimental studies on the pathogenesis of toxic effects of styrene. I. Evaluation of the role of styrene in the occurrence of occupational dermatoses Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia 26(3-4): 289-297
Shashkov, V.S.; Drozd, Y.V.; Yasnetsov, V.V.; Galkina, E.Yu; Ryumin, Y.I. 1988: Role of opioid peptides in the pathogenesis of vestibulo-autonomic disorders Kosmicheskaia Biologiia i Aviakosmicheskaia Meditsina 22(1): 37-40
Efimov, A.S.; Slavnov, V.N.; Buglak, N.I. 1972: Role of vascular permeability disorders in the pathogenesis of diabetic angiopathies Terapevticheskii Arkhiv 44(7): 32-34
Veĭn, A.M.; Rodshtat, I.V. 1972: The role of psycho-autonomic disorders in the pathogenesis of somatic diseases Klinicheskaia Meditsina 50(9): 6-11
Bodnar, P.N. 1973: Role of protein metabolic disorders in the pathogenesis of diabetic angiopathies Problemy Endokrinologii 19(2): 3-7
Kantardzhian, I.G. 1976: The role of insulin deficit in the pathogenesis of several lipid metabolism disorders Problemy Endokrinologii 22(3): 95-99